Excellent Opportunity: to acquire the Orchestra Therapeutics cGMP Vaccines Manufacturing Facility in King of Prussia, Pennsylvania (suburban Philadelphia). The facility was designed to develop and manufacture vaccines for clinical Phase I, II and III studies as well as commercial Launch. At this scale, Orchestra Therapeutics has considerable excess capacity and has an interest in selling its assets in King of Prussia or leasing the facility. Inquiries should be directed to PharmaBioSource Realty, LLC.